Syndax Pharmaceuticals Inc - FORM S-1 - EX-23.1 - January 4, 2016

Attached files

file filename
S-1 - FORM S-1 - Syndax Pharmaceuticals Incd39288ds1.htm
EX-3.4 - EX-3.4 - Syndax Pharmaceuticals Incd39288dex34.htm
EX-4.1 - EX-4.1 - Syndax Pharmaceuticals Incd39288dex41.htm
EX-3.1 - EX-3.1 - Syndax Pharmaceuticals Incd39288dex31.htm
EX-1.1 - EX-1.1 - Syndax Pharmaceuticals Incd39288dex11.htm
EX-3.2 - EX-3.2 - Syndax Pharmaceuticals Incd39288dex32.htm
EX-3.3 - EX-3.3 - Syndax Pharmaceuticals Incd39288dex33.htm
EX-4.2 - EX-4.2 - Syndax Pharmaceuticals Incd39288dex42.htm
EX-10.3 - EX-10.3 - Syndax Pharmaceuticals Incd39288dex103.htm
EX-10.5 - EX-10.5 - Syndax Pharmaceuticals Incd39288dex105.htm
EX-10.2 - EX-10.2 - Syndax Pharmaceuticals Incd39288dex102.htm
EX-10.6 - EX-10.6 - Syndax Pharmaceuticals Incd39288dex106.htm
EX-10.4 - EX-10.4 - Syndax Pharmaceuticals Incd39288dex104.htm
EX-10.9 - EX-10.9 - Syndax Pharmaceuticals Incd39288dex109.htm
EX-10.8 - EX-10.8 - Syndax Pharmaceuticals Incd39288dex108.htm
EX-10.1 - EX-10.1 - Syndax Pharmaceuticals Incd39288dex101.htm
EX-10.7 - EX-10.7 - Syndax Pharmaceuticals Incd39288dex107.htm
EX-10.28 - EX-10.28 - Syndax Pharmaceuticals Incd39288dex1028.htm
EX-10.22 - EX-10.22 - Syndax Pharmaceuticals Incd39288dex1022.htm
EX-10.30 - EX-10.30 - Syndax Pharmaceuticals Incd39288dex1030.htm
EX-10.21 - EX-10.21 - Syndax Pharmaceuticals Incd39288dex1021.htm
EX-10.26 - EX-10.26 - Syndax Pharmaceuticals Incd39288dex1026.htm
EX-10.29 - EX-10.29 - Syndax Pharmaceuticals Incd39288dex1029.htm
EX-10.18 - EX-10.18 - Syndax Pharmaceuticals Incd39288dex1018.htm
EX-10.16 - EX-10.16 - Syndax Pharmaceuticals Incd39288dex1016.htm
EX-10.17 - EX-10.17 - Syndax Pharmaceuticals Incd39288dex1017.htm
EX-10.25 - EX-10.25 - Syndax Pharmaceuticals Incd39288dex1025.htm
EX-10.12 - EX-10.12 - Syndax Pharmaceuticals Incd39288dex1012.htm
EX-10.24 - EX-10.24 - Syndax Pharmaceuticals Incd39288dex1024.htm
EX-10.27 - EX-10.27 - Syndax Pharmaceuticals Incd39288dex1027.htm
EX-10.11 - EX-10.11 - Syndax Pharmaceuticals Incd39288dex1011.htm
EX-10.19 - EX-10.19 - Syndax Pharmaceuticals Incd39288dex1019.htm
EX-10.32 - EX-10.32 - Syndax Pharmaceuticals Incd39288dex1032.htm
EX-10.15 - EX-10.15 - Syndax Pharmaceuticals Incd39288dex1015.htm
EX-10.13 - EX-10.13 - Syndax Pharmaceuticals Incd39288dex1013.htm
EX-10.10 - EX-10.10 - Syndax Pharmaceuticals Incd39288dex1010.htm
EX-10.20 - EX-10.20 - Syndax Pharmaceuticals Incd39288dex1020.htm
EX-10.31 - EX-10.31 - Syndax Pharmaceuticals Incd39288dex1031.htm
EX-10.14 - EX-10.14 - Syndax Pharmaceuticals Incd39288dex1014.htm
EX-21.1 - EX-21.1 - Syndax Pharmaceuticals Incd39288dex211.htm
EX-10.33 - EX-10.33 - Syndax Pharmaceuticals Incd39288dex1033.htm
EX-10.35 - EX-10.35 - Syndax Pharmaceuticals Incd39288dex1035.htm
EX-10.34 - EX-10.34 - Syndax Pharmaceuticals Incd39288dex1034.htm
EX-10.23 - EX-10.23 - Syndax Pharmaceuticals Incd39288dex1023.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the use in this Registration Statement on Form S-1 of our report dated August 24, 2015 relating to the consolidated financial statements of Syndax Pharmaceuticals, Inc. and subsidiaries, appearing in the Prospectus, which is part of this Registration Statement.

We also consent to the reference to us under the heading “Experts” in such Prospectus.

 

/s/ Deloitte & Touche LLP
Boston, Massachusetts
January 4, 2016

Syndax Pharmaceuticals Inc Reports